Feeling a Little SYK after Mixing BAFF with BCR  by Infantino, Simona & Tarlinton, David M.
Immunity
Previewsnor a specific treatment to permanently
restore glandular secretion, so these
exciting experimental data may open
new avenues for the treatment of this
devastating disorder. Thus, future studies
should investigate the significance of
STAT3-mediated IkB-z-dependent in-
creased apoptosis in human SS dis-
ease and other autoimmune pathologies
in which aberrant apoptosis has been
noted.
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In this issue of Immunity, Schweighoffer et al. (2013) report that full BAFF responsiveness in B cells requires
the tyrosine kinase Syk and that BAFF may co-opt components of the B cell receptor in transmitting its
survival signal.It is axiomatic to mammalian immune
system function that adequate popula-
tions of recirculating B and T lympho-
cytes bearing unique antigen-binding
receptors are maintained in peripheral
lymphoid organs. The maintenance of
mature B cells in this steady state
requires the continuous receipt and
appropriate processing of environmental
cues. There are two receptors expressed
by B cells that are crucial for maintaining
B cell survival in the periphery; the clon-
ally restricted B cell receptor (BCR) for
antigen and the general receptor for
BAFF (B cell activating factor; BLyS),
a member of the TNF superfamily of
receptors. Although originally considered
independent, the redundancy, intersec-
tion, and crosstalk between the signaling
pathways triggered by these two media-
tors of B cell viability have been matters
of debate over many years (Mackay
et al., 2010; Rickert et al., 2011). In this
issue of Immunity, Schweighoffer et al.make a dramatic addition to this topic
by providing compelling evidence that
BAFF signaling impinges on components
of the BCR itself and requires the
kinase Syk, a key enzyme downstream
of the BCR (Schweighoffer et al., 2013).
Thus our understanding of BAFF-driven
B cell survival appears to be incomplete
and the signaling pathways emanat-
ing from the BAFFR and BCR might
share common, crucial, ligand-proximal
elements.
BAFFR and BCR signaling are
complex and multifaceted, not all of
which are required for B cell survival
(Figure 1). Elegant experiments showed
conclusively that the survival com-
ponent of BCR signaling could be
substituted completely and exclusively
by a constitutively active form of the
lipid-metabolizing enzyme, phosphoi-
nositide-3-kinase (PI3K) (Srinivasan
et al., 2009). Survival signaling through
BAFFR, however, despite activatingPI3K, depends on the noncanonical
(or alternate) pathway of NF-kB (re-
viewed (Rickert et al., 2011)). Although
the intersections of these two path-
ways were reviewed recently (Mackay
et al., 2010; Rickert et al., 2011), it
is sufficient here to note the following.
First, activation of PI3K is necessary
and sufficient for BCR-mediated survival
and necessary but insufficient for
BAFFR-mediated survival. Second, acti-
vation of PI3K and ERK downstream of
BAFF is biphasic with early and late
peaks, the latter requiring noncanonical
NF-kB signaling (Otipoby et al., 2008;
Patke et al., 2006). Third, withdrawal of
BAFF or the BCR has different conse-
quences; BCR deficiency leads to rapid
loss of all B cells while loss of BAFF
leaves B1 cells in the peritoneal cavity
unaffected. Fourth, BCR stimulation is
required to upregulate BAFFR during
development, and fifth, the canonical
NF-kB pathway downstream of the
Figure 1. BAFFR Signaling Incorporating the Activation of Syk and Leading to B Cell Survival
BAFF binding to BAFFR leads to the early (min; blue) activation of Syk through the activation of Src family
kinases (Src) and by binding to the phosphorylated ITAM of Ig-a. Active Syk leads to the late activation of
PI3K and Akt (hr; orange), which promotes survival (green) by inhibiting proapoptotic proteins. Syk is also
involved in BAFF-mediated activation of Erk1/2 (early) and the canonical NF-kB pathway (not shown).
BAFF also induces Syk-independent activation of the noncanonical NF-kBpathway, leading to prosurvival
gene expression (green) and late PI3K activation (orange).
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PreviewsBCR produces NF-kB p100, a sub-
strate for the noncanonical pathway
activated by BAFF. Whereas most of
the debate on the interrelationship
between BAFF and BCR has focused
on the endlessly fascinating topic of the
canonical and noncanonical NF-kB path-
ways (Mackay et al., 2010; Rickert et al.,
2011), the activation of the lipid-metabo-
lizing enzyme PI3K by BAFF remains
unexplained.
Schweighoffer et al. induced the loss
of Syk from mature B cells and found
that it was required to transmit survival
signals in follicular and marginal zone
B cells but not B1 cells. The similarity
with BAFF deficiency prompted exami-
nation of the involvement of Syk in BAFF
responsiveness in vitro and this, unex-
pectedly, was found to be deficient.
Continuing with unexpected outcomes,
Schweighoffer et al. also discovered
that BAFF induced the rapid phospho-
rylation of both Syk and the BCR signal-
ing subunit, Ig-a (Figure 1), establishing
a very proximal connection between
BAFF and the BCR. Previous identifi-
cation of PI3K as being activated by
both BCR and BAFF and as mediating
the BCR survival signal (Srinivasan
et al., 2009) suggest that PI3K could
represent the outcome of some crucial
crosstalk in these two survival pathways
(Figure 1). Consistent with this, Schweigh-offer et al. show that Syk is required in
B cells for BAFF to increase baseline
phosphorylation of Akt, a known target
of PI3K. The conditional deletion of
PTEN or PDK1 provided additional
evidence placing PI3K downstream of
BAFF and Syk.
Several ‘‘simple’’ explanations for the
requirement for Syk in BAFF signaling
were excluded by Schweighoffer et al.
with varying degrees of certainty. BAFFR
expression and activation of the nonca-
nonical pathway of NF-kB were shown
not to be limiting in the absence of Syk
for B cell survival and BAFF responsive-
ness. Because stimulation along the
BCR and BAFFR pathways induces
phosphorylation of ERK, the authors
examined whether constitutively active
MEK1 (caMEK1) could counteract the
loss of Syk. Somewhat curiously, they
found that the ectopic expression of
caMEK1 enhanced the in vivo survival
of Syk-deficient B cells but had no
effect on BAFF responsiveness in vitro,
suggesting a partial involvement in
modulating B cell survival. Lastly, the
requirement for Syk activity, as opposed
to Syk structure, in mediating BAFF-
dependent B cell survival was demon-
strated by ectopically expressing Syk or
Syk kinase dead (KD) in both control
and Syk-deficient B cells (Schweighoffer
et al., 2013).Immunity 3These data support the conclusion that
BAFF sustains B cell survival in vivo by
mandatorily activating Syk. Is this so
and if so, how, given that Syk activation
requires phosphorylated ITAMs as dock-
ing sites for its two tandemSH2 domains?
Schweighoffer et al. found that BAFF
stimulation of B cells did indeed induce
the rapid phosphorylation of Syk (Fig-
ure 1). As for the ITAM, Schweighoffer
et al. provide data that Ig-a, a BCR
signaling subunit, is tyrosine phosphory-
lated in response to BAFF (Figure 1).
Although the mechanics behind BAFF-
dependent Ig-a phosphorylation remain
to be determined, Schweighoffer et al.
show that inhibition of Src-family kinases
impairs BAFF-induced Syk activation
and consequently in vitro B cell survival
in the presence of BAFF (Figure 1).
By showing a requirement for Syk,
Schweighoffer et al. have discovered,
at a minimum, exciting and unexpected
new steps in BAFF signaling involving
Src family kinases, phosphorylated
ITAMs, and Syk, finishing in PI3K and
MAPK. As the authors note, other ITAMs
to which Syk can bind could contribute
to BAFF signaling, but if one accepts the
implication that following exposure to
BAFF, phosphorylated Ig-a is a point of
recruitment and activation of Syk, then
this study puts a new complexion on
the concept of crosstalk between BCR
and BAFFR. It suggests that BAFF
might activate both its own well-defined
pathway and several facets of the path-
ways arising from the BCR, possibly
activating both survival components.
There remain important questions in
addition to the mechanical ones already
mentioned. Is there any role in this
process for TACI, an alternate receptor
for BAFF expressed by B cells? Is
the PI3K activity induced by Syk by
BAFF sufficient for survival in the absence
of a BCR signal or are there different,
early and late, pools of PI3K activated
by these two receptors that combined
mediate survival? Does the biphasic
activation of PI3K by BAFF reflect Syk
acting early and noncanonical NF-kB
late (Figure 1)? Although unraveling
these two apparently intimately linked
pathways is a technically challenging
proposal, it remains crucial in deter-
mining whether BCR tonic signaling is
independent of, or commandeered by,
BAFF.8, March 21, 2013 ª2013 Elsevier Inc. 407
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Monocyte-macrophage differentiation under pathological conditions is poorly understood. In the present
issue of Immunity, Egawa et al. (2013) report how basophils drive the differentiation of inflammatory mono-
cytes into M2 macrophages, thereby regulating allergic skin inflammation.Monocytes and macrophages can per-
form a diverse range of functions under
homeostatic and pathogenic conditions.
This is facilitated by the existence of
distinct subsets with specific functions
and the ability to switch between dif-
ferent functional phenotypes in response
to microenvironmental cues. Two main
monocyte subsets have been recognized,
namely the Ly6ChiCCR2+ and Ly6Clo
CX3CR1+ monocytes in mice and the
corresponding CD14+CD16 and CD16+
CD14dim monocytes in humans (Geiss-
mann et al., 2010). The Ly6ChiCCR2+
‘‘inflammatory’’ monocytes infiltrate in-
flamed tissue, produce inflammatory
cytokines, and are involved in host re-
sponse to infection. The Ly6CloCX3CR1+
monocytes ‘‘patrol’’ blood vessels under
steady state, extravasate during tissue
injury, and promote tissue repair and
healing. Similarly in macrophages, at least
two main types of functional activation
states exist: the M1 (or classically acti-
vated) and the M2 (or alternatively acti-
vated) macrophages. Microbial stimuli
and T helper 1 (Th1) cell-related cytokines
(such as IFN-g) trigger the M1 phenotype,
which promotes inflammation, Th1 cell
responses, and microbicidal-tumoricidal
functions. Th2 cell-related cytokines
(such as interleukin-4 [IL-4], IL-13, andIL-10) trigger the M2 state, which
dampens excessive inflammation and
promotes Th2 cell responses, tissue re-
modeling, protumor functions, and clear-
ance of parasites (Biswas and Mantovani,
2010). However, M1 and M2 represent
two extremes of a spectrum of macro-
phage functional states that may exist
in vivo.
A key question arising from the above
context is the relationship between the
monocyte subsets and the macrophage
activation states. In addition, the in vivo
microenvironmental cues and interact-
ing cells that induce monocyte-macro-
phage differentiation to distinct functional
phenotypes, especially under patho-
logical settings, is poorly understood.
Addressing these areas, Egawa et al.
(2013) in the present issue of Immunity
investigate monocyte-macrophage differ-
entiation in immunoglobulin E (IgE)-medi-
ated skin allergic inflammation (IgE-CAI),
uncovering a crucial role for basophils
therein (Figure 1).
In mice sensitized with allergen-
specific IgE, IgE-CAI was characterized
by late-phase ear swelling after intra-
dermal allergen challenge and was
dependent on basophils. The skin
lesions showed increased infiltration of
Ly6C+CCR2+ monocyte-macrophagesand CCR2+ basophils and expression
of CCR2 ligands CCL8 and CCL12.
Based on these observations, a key role
for CCR2 in the recruitment of these
cells and the development of IgE-CAI
was suggested. Contrary to this expecta-
tion, Ccr2/ mice showed exacerbated
IgE-CAI with abolished monocyte-macro-
phage infiltration in the skin lesion but
enhanced infiltration of basophils (as
well as neutrophils), suggesting CCR2 to
be dispensable for basophil recruitment.
Further investigation profiling monocyte-
macrophages from IgE-CAI skin lesions
of wild-type mice revealed that the
majority of these cells expressed the
inhibitory molecule and M2 marker, Pro-
grammed Death 1 ligand 2 (PD-L2),
together with other M2 genes like Arg1,
Chi3l3, and Fizz1, indicating an M2
phenotype (Figure 1). Experiments via
adoptive transfer of CD115+ bonemarrow
monocytes or inflammatory monocytes
confirmed that inflammatory monocytes
infiltrate skin lesions and differentiate
into M2 macrophages, which in turn
dampened the allergic inflammation, as
demonstrated by their ability to attenuate
the exacerbated IgE-CAI in Ccr2/
animals.
Several scenarios have emerged on the
relationship between monocyte subsets
